TNSN01131A1 - NOVEL PHENOXYBENZYLAMINE DERIVATIVES, PROCESS FOR THEIR PREPARATION AND COMPOSITIONS CONTAINING THEM. - Google Patents
NOVEL PHENOXYBENZYLAMINE DERIVATIVES, PROCESS FOR THEIR PREPARATION AND COMPOSITIONS CONTAINING THEM.Info
- Publication number
- TNSN01131A1 TNSN01131A1 TNTNSN01131A TNSN01131A TNSN01131A1 TN SN01131 A1 TNSN01131 A1 TN SN01131A1 TN TNSN01131 A TNTNSN01131 A TN TNSN01131A TN SN01131 A TNSN01131 A TN SN01131A TN SN01131 A1 TNSN01131 A1 TN SN01131A1
- Authority
- TN
- Tunisia
- Prior art keywords
- preparation
- compositions containing
- phenoxybenzylamine
- derivatives
- novel
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/30—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/37—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups having the sulfur atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/60—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
- C07D277/62—Benzothiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
- A61K31/343—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
- A61K31/381—Heterocyclic compounds having sulfur as a ring hetero atom having five-membered rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
- A61K31/39—Heterocyclic compounds having sulfur as a ring hetero atom having oxygen in the same ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/01—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms
- C07C311/02—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
- C07C311/08—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton having the nitrogen atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
- C07C323/10—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and singly-bound oxygen atoms bound to the same carbon skeleton
- C07C323/18—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and singly-bound oxygen atoms bound to the same carbon skeleton having the sulfur atom of at least one of the thio groups bound to a carbon atom of a six-membered aromatic ring of the carbon skeleton
- C07C323/20—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and singly-bound oxygen atoms bound to the same carbon skeleton having the sulfur atom of at least one of the thio groups bound to a carbon atom of a six-membered aromatic ring of the carbon skeleton with singly-bound oxygen atoms bound to carbon atoms of the same non-condensed six-membered aromatic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/20—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
- C07D239/72—Quinazolines; Hydrogenated quinazolines
- C07D239/74—Quinazolines; Hydrogenated quinazolines with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached to ring carbon atoms of the hetero ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/87—Benzo [c] furans; Hydrogenated benzo [c] furans
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D327/00—Heterocyclic compounds containing rings having oxygen and sulfur atoms as the only ring hetero atoms
- C07D327/02—Heterocyclic compounds containing rings having oxygen and sulfur atoms as the only ring hetero atoms one oxygen atom and one sulfur atom
- C07D327/06—Six-membered rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
- C07D333/52—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
- C07D333/54—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
- C07D333/72—Benzo[c]thiophenes; Hydrogenated benzo[c]thiophenes
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2602/00—Systems containing two condensed rings
- C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
- C07C2602/04—One of the condensed rings being a six-membered aromatic ring
- C07C2602/08—One of the condensed rings being a six-membered aromatic ring the other ring being five-membered, e.g. indane
Abstract
L'INVENTION CONCERNE DES COMPOSES DE FORMULE GENERALE I : DANS LQUELLE R1, R2, R4, R5, Y ET Z REPRESENTENT DIVERS RADICAUX. ELLE CONCERNE EGALEMENT UN PROCEDE POUR LA PREPARATION ET DES COMPOSITIONS LES CONTENANT. APPLICATION : UTILISATION DE CES COMPOSES, COMME INHIBITEURS DE REABSOPTION DE SEROTONINE SELECTIFS, POUR LE TRAITEMENT DE DIVERSES MALADIES.THE INVENTION CONCERNS COMPOUNDS OF GENERAL FORMULA I IN WHICH R1, R2, R4, R5, Y AND Z REPRESENT VARIOUS RADICALS. IT ALSO CONCERNS A PROCESS FOR THE PREPARATION AND COMPOSITIONS CONTAINING THEM. APPLICATION: USE OF THESE COMPOUNDS AS SELECTIVE SEROTONIN REABSOPTION INHIBITORS FOR THE TREATMENT OF VARIOUS ILLNESSES.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB0021593A GB0021593D0 (en) | 2000-08-31 | 2000-08-31 | Diphenyl ether compounds useful in therapy |
GB0107116A GB0107116D0 (en) | 2001-03-21 | 2001-03-21 | Novel compounds |
Publications (1)
Publication Number | Publication Date |
---|---|
TNSN01131A1 true TNSN01131A1 (en) | 2005-11-10 |
Family
ID=26244953
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
TNTNSN01131A TNSN01131A1 (en) | 2000-08-31 | 2001-08-30 | NOVEL PHENOXYBENZYLAMINE DERIVATIVES, PROCESS FOR THEIR PREPARATION AND COMPOSITIONS CONTAINING THEM. |
Country Status (32)
Country | Link |
---|---|
EP (1) | EP1313701A1 (en) |
JP (1) | JP2004507523A (en) |
KR (1) | KR20030029889A (en) |
CN (1) | CN1449380A (en) |
AP (1) | AP2001002265A0 (en) |
AR (1) | AR031867A1 (en) |
AU (1) | AU2001278650A1 (en) |
BG (1) | BG107544A (en) |
BR (1) | BR0113610A (en) |
CA (1) | CA2420969A1 (en) |
CZ (1) | CZ2003467A3 (en) |
DO (1) | DOP2001000242A (en) |
DZ (1) | DZ3414A1 (en) |
EA (1) | EA200300206A1 (en) |
EE (1) | EE200300084A (en) |
HN (1) | HN2001000191A (en) |
HR (1) | HRP20030141A2 (en) |
HU (1) | HUP0303385A2 (en) |
IL (1) | IL154343A0 (en) |
IS (1) | IS6704A (en) |
MA (1) | MA26945A1 (en) |
MX (1) | MXPA03001848A (en) |
NO (1) | NO20030842L (en) |
NZ (1) | NZ523951A (en) |
OA (1) | OA12372A (en) |
PA (1) | PA8526701A1 (en) |
PE (1) | PE20020346A1 (en) |
PL (1) | PL360743A1 (en) |
SK (1) | SK2012003A3 (en) |
TN (1) | TNSN01131A1 (en) |
UY (1) | UY26924A1 (en) |
WO (1) | WO2002018333A1 (en) |
Families Citing this family (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6403597B1 (en) * | 1997-10-28 | 2002-06-11 | Vivus, Inc. | Administration of phosphodiesterase inhibitors for the treatment of premature ejaculation |
US6436938B1 (en) * | 2001-01-22 | 2002-08-20 | Pfizer Inc. | Combination treatment for depression |
US20020107244A1 (en) * | 2001-02-02 | 2002-08-08 | Howard Harry R. | Combination treatment for depression |
US20020183306A1 (en) * | 2001-05-30 | 2002-12-05 | Pfizer Inc. | Combination treatment for sleep disorders including sleep apnea |
GB0318706D0 (en) * | 2003-08-08 | 2003-09-10 | Pfizer Ltd | Selective serotonin reuptake inhibitors in the treatment of disease |
JP3997255B2 (en) | 2004-02-13 | 2007-10-24 | ワーナー−ランバート カンパニー リミテッド ライアビリティー カンパニー | Androgen receptor modulator |
US7507860B2 (en) | 2004-04-13 | 2009-03-24 | Pfizer Inc. | Androgen modulators |
WO2005102990A1 (en) | 2004-04-22 | 2005-11-03 | Warner-Lambert Company Llc | Androgen modulators |
BRPI0513020A (en) | 2004-07-08 | 2008-04-22 | Warner Lambert Co | androgen modulators, their uses, pharmaceutical composition, topical pharmaceutical formulation and article of manufacture |
MX2007001993A (en) * | 2004-08-18 | 2007-05-10 | Warner Lambert Co | Androgen modulators. |
EP1791807A1 (en) * | 2004-09-10 | 2007-06-06 | Pfizer Products Incorporated | Therapeutic diphenyl ether ligands |
TW200724139A (en) | 2005-05-05 | 2007-07-01 | Warner Lambert Co | Androgen modulators |
WO2007010350A1 (en) * | 2005-07-19 | 2007-01-25 | Pfizer Products Inc. | Synthesis of therapeutic diphenyl ethers |
US7939528B2 (en) | 2005-10-13 | 2011-05-10 | Glaxosmithkline Llc | Heterocycle compounds |
WO2007076875A2 (en) * | 2006-01-06 | 2007-07-12 | Aarhus Universitet | Compounds acting on the serotonin transporter |
CA2656075A1 (en) | 2006-06-29 | 2008-01-03 | Janssen Pharmaceutica N.V. | Butyl and butynyl benzyl amine compounds |
CA2656089A1 (en) * | 2006-06-29 | 2008-01-03 | Janssen Pharmaceutica N.V. | Substituted benzyl amine compounds |
CN101511790A (en) * | 2006-06-29 | 2009-08-19 | 詹森药业有限公司 | Substituted aminomethyl benzamide compounds |
US8642583B2 (en) | 2008-10-30 | 2014-02-04 | Janssen Pharmaceutica Nv | Serotonin receptor modulators |
WO2010059390A1 (en) | 2008-10-30 | 2010-05-27 | Janssen Pharmaceutica Nv | Modulators of serotonin receptor |
KR101043200B1 (en) * | 2010-11-08 | 2011-06-21 | 성시민 | Air charging device for respiration air tank |
GB2501206B (en) | 2011-01-27 | 2019-12-04 | Hewlett Packard Development Co | A computing device to connect to a portable device |
US20220185815A1 (en) | 2019-03-06 | 2022-06-16 | Daiichi Sankyo Company, Limited | Pyrrolopyrazole derivative |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ZA923283B (en) * | 1991-05-29 | 1993-01-27 | Akzo Nv | Phenoxyphenyl derivatives |
EP0714391A1 (en) * | 1993-08-19 | 1996-06-05 | Warner-Lambert Company | Substituted 2(5h)furanone, 2(5h)thiophenone and 2(5h)pyrrolone derivatives, their preparation and their use as endothelin antagonists |
CZ293595A3 (en) * | 1995-11-09 | 1999-12-15 | Farmak A. S. | Derivatives of n,n-dimethyl-2-(arylthio)benzylamine, their salts, processes of their preparation and their use in medicaments |
EP1071648A2 (en) * | 1998-03-13 | 2001-01-31 | Merck Frosst Canada & Co. | Carboxylic acids and acylsulfonamides, compositions containing such compounds and methods of treatment |
NZ512910A (en) * | 1999-02-23 | 2003-11-28 | Pfizer Prod Inc | Monoamine reuptake inhibitors for treatment of CNS disorders |
GB0007884D0 (en) * | 2000-03-31 | 2000-05-17 | Pfizer Ltd | Diphenyl ether compounds useful in therapy |
-
2001
- 2001-08-22 EA EA200300206A patent/EA200300206A1/en unknown
- 2001-08-22 NZ NZ523951A patent/NZ523951A/en unknown
- 2001-08-22 EP EP01956734A patent/EP1313701A1/en not_active Withdrawn
- 2001-08-22 EE EEP200300084A patent/EE200300084A/en unknown
- 2001-08-22 KR KR10-2003-7003011A patent/KR20030029889A/en not_active Application Discontinuation
- 2001-08-22 PL PL36074301A patent/PL360743A1/en not_active Application Discontinuation
- 2001-08-22 SK SK201-2003A patent/SK2012003A3/en unknown
- 2001-08-22 HU HU0303385A patent/HUP0303385A2/en unknown
- 2001-08-22 IL IL15434301A patent/IL154343A0/en unknown
- 2001-08-22 WO PCT/IB2001/001521 patent/WO2002018333A1/en not_active Application Discontinuation
- 2001-08-22 DZ DZ013414A patent/DZ3414A1/en active
- 2001-08-22 AP APAP/P/2001/002265A patent/AP2001002265A0/en unknown
- 2001-08-22 AU AU2001278650A patent/AU2001278650A1/en not_active Abandoned
- 2001-08-22 CN CN01814846A patent/CN1449380A/en active Pending
- 2001-08-22 JP JP2002523451A patent/JP2004507523A/en active Pending
- 2001-08-22 CZ CZ2003467A patent/CZ2003467A3/en unknown
- 2001-08-22 OA OA1200300056A patent/OA12372A/en unknown
- 2001-08-22 CA CA002420969A patent/CA2420969A1/en not_active Abandoned
- 2001-08-22 MX MXPA03001848A patent/MXPA03001848A/en active IP Right Grant
- 2001-08-22 BR BR0113610-0A patent/BR0113610A/en not_active IP Right Cessation
- 2001-08-24 PA PA20018526701A patent/PA8526701A1/en unknown
- 2001-08-28 HN HN2001000191A patent/HN2001000191A/en unknown
- 2001-08-28 PE PE2001000862A patent/PE20020346A1/en not_active Application Discontinuation
- 2001-08-29 DO DO2001000242A patent/DOP2001000242A/en unknown
- 2001-08-29 AR ARP010104114A patent/AR031867A1/en unknown
- 2001-08-30 TN TNTNSN01131A patent/TNSN01131A1/en unknown
- 2001-08-31 UY UY26924A patent/UY26924A1/en not_active Application Discontinuation
-
2003
- 2003-01-30 IS IS6704A patent/IS6704A/en unknown
- 2003-02-07 BG BG107544A patent/BG107544A/en unknown
- 2003-02-21 MA MA27049A patent/MA26945A1/en unknown
- 2003-02-24 NO NO20030842A patent/NO20030842L/en not_active Application Discontinuation
- 2003-02-26 HR HR20030141A patent/HRP20030141A2/en not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
PE20020346A1 (en) | 2002-05-08 |
MA26945A1 (en) | 2004-12-20 |
EP1313701A1 (en) | 2003-05-28 |
PA8526701A1 (en) | 2003-07-28 |
EA200300206A1 (en) | 2003-06-26 |
JP2004507523A (en) | 2004-03-11 |
OA12372A (en) | 2006-04-17 |
NZ523951A (en) | 2004-09-24 |
CA2420969A1 (en) | 2002-03-07 |
IL154343A0 (en) | 2003-09-17 |
MXPA03001848A (en) | 2003-06-04 |
UY26924A1 (en) | 2002-03-22 |
CZ2003467A3 (en) | 2004-04-14 |
EE200300084A (en) | 2005-02-15 |
BG107544A (en) | 2003-10-31 |
KR20030029889A (en) | 2003-04-16 |
HRP20030141A2 (en) | 2003-04-30 |
IS6704A (en) | 2003-01-30 |
NO20030842D0 (en) | 2003-02-24 |
PL360743A1 (en) | 2004-09-20 |
WO2002018333A1 (en) | 2002-03-07 |
HUP0303385A2 (en) | 2004-03-01 |
BR0113610A (en) | 2003-06-24 |
CN1449380A (en) | 2003-10-15 |
DOP2001000242A (en) | 2002-05-15 |
AR031867A1 (en) | 2003-10-08 |
HN2001000191A (en) | 2002-03-11 |
NO20030842L (en) | 2003-04-28 |
AP2001002265A0 (en) | 2001-09-30 |
AU2001278650A1 (en) | 2002-03-13 |
SK2012003A3 (en) | 2004-06-08 |
DZ3414A1 (en) | 2002-03-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
TNSN01131A1 (en) | NOVEL PHENOXYBENZYLAMINE DERIVATIVES, PROCESS FOR THEIR PREPARATION AND COMPOSITIONS CONTAINING THEM. | |
TNSN99170A1 (en) | NOVEL SUBSTITUTED TETRAHYDROQUINOLEIN DERIVATIVES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | |
MA26720A1 (en) | NOVEL MONOAMINE REABSORPTION INHIBITORS, PROCESSES FOR THEIR PREPARATION, AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM. | |
TNSN99236A1 (en) | NOVEL SUBSTITUTED BICYCLIC DERIVATIVES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM. | |
TNSN01047A1 (en) | PROCESS FOR THE PREPARATION OF NEW PIPERAZINE DERIVATIVES | |
TNSN99162A1 (en) | NEW ALCYNYL SUBSTITUTE QUINOLEIN-2-ONE DERIVATIVES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | |
TNSN01126A1 (en) | NOVEL SUBSTITUTED IMIDAZOLES, PROCESS FOR THEIR PREPARATION AND COMPOSITIONS CONTAINING THEM | |
MA26718A1 (en) | NEW HETEROARYL SUBSTITUTE QUINOLEIN-2-ONE DERIVATIVES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | |
TNSN02032A1 (en) | NOVEL N-PHENPROPYLCYCLOPENTYL SUBSTITUTED GLUTARAMIDE DERIVATIVES AND COMPOSITIONS CONTAINING THE SAME. | |
TNSN98238A1 (en) | NEW MACROLIDES | |
TNSN99142A1 (en) | NOVEL BENZIMIDAZOLE DERIVATIVES, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND PROCESS FOR THEIR PREPARATION. | |
TNSN01102A1 (en) | NOVEL PYRAZOLE DERIVATIVES, PROCESS FOR THEIR PREPARATION AND COMPOSITIONS CONTAINING THEM. | |
TNSN97144A1 (en) | SUBSTITUTED 6,6-HETEROBICYCLIC DERIVATIVES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | |
TNSN99126A1 (en) | NOVEL PYRROLOPYRIMIDINES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | |
TNSN99125A1 (en) | NEW PYRROLO (2,3-D) PYRIMIDINES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | |
TNSN98082A1 (en) | SUBSTITUTED DERIVATIVES IN C - 4 OF 9 - DESOXO - 9a - aza - 9a HOMOERYTHROMYCIN A. | |
TNSN99156A1 (en) | NOVEL HYDROXYPIPECOLATE-HYDROXAMIC ACID DERIVATIVES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | |
TNSN99006A1 (en) | 4- (2-CETO-1-BENZIMIDAZOLINYL) NOVEL PIPERIDINES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | |
TNSN02011A1 (en) | NOVEL BICYCLIC PYRIMIDINE DERIVATIVES, MMP INHIBITORS, AND COMPOSITIONS CONTAINING THEM | |
TNSN98045A1 (en) | NOVEL NICOTINAMIDE DERIVATIVES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM. | |
TNSN02014A1 (en) | NOVEL PPAR AGONIST COMPOUNDS AND COMPOSITIONS CONTAINING SAME | |
TNSN99073A1 (en) | NOVEL PYRAZOLOPYRIMIDINONES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | |
TNSN99106A1 (en) | NOVEL ISOTHIAZOLE DERIVATIVES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM. | |
TNSN98182A1 (en) | NOVEL PROSTAGLANDIN AGONISTS, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | |
TNSN97190A1 (en) | DERIVATIVES OF BICYCLIC AMINES. |